JW Pharmaceutical Corporation (KRX:001065)
South Korea flag South Korea · Delayed Price · Currency is KRW
28,150
-1,300 (-4.41%)
Feb 26, 2026, 12:30 PM KST

JW Pharmaceutical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
844,269561,695828,523419,688505,678753,056
Market Cap Growth
52.08%-32.20%97.41%-17.00%-32.85%22.16%
Enterprise Value
830,421600,784959,912491,395649,827873,041
Last Close Price
29450.0029650.0032657.1429902.4631049.5535456.20
PE Ratio
14.569.2422.3913.16--
PS Ratio
1.100.781.110.610.831.38
PB Ratio
2.381.713.121.862.683.63
P/TBV Ratio
2.461.763.291.842.683.86
P/FCF Ratio
10.827.9013.848.9647.4514.86
P/OCF Ratio
9.627.089.517.3927.9011.94
EV/Sales Ratio
1.090.841.280.721.071.60
EV/EBITDA Ratio
7.055.908.056.3613.8445.08
EV/EBIT Ratio
8.397.269.938.1221.07-
EV/FCF Ratio
10.648.4516.0310.4960.9817.23
Debt / Equity Ratio
0.190.280.640.931.300.88
Debt / EBITDA Ratio
0.590.901.432.715.229.41
Debt / FCF Ratio
0.881.292.844.4723.003.60
Net Debt / Equity Ratio
-0.040.180.290.270.950.61
Net Debt / EBITDA Ratio
-0.120.580.640.773.826.55
Net Debt / FCF Ratio
-0.180.831.271.2816.842.51
Asset Turnover
1.221.151.181.091.030.98
Inventory Turnover
3.543.643.793.703.653.86
Quick Ratio
0.940.820.900.800.790.78
Current Ratio
1.511.471.321.121.301.27
Return on Equity (ROE)
19.09%21.87%15.65%14.41%-0.73%-6.98%
Return on Assets (ROA)
9.74%8.28%9.49%6.00%3.26%-0.15%
Return on Invested Capital (ROIC)
19.92%17.88%21.60%12.18%-0.62%-0.37%
Return on Capital Employed (ROCE)
24.90%20.90%27.00%24.40%8.80%-0.40%
Earnings Yield
6.87%11.58%4.47%7.60%-0.19%-2.02%
FCF Yield
9.24%12.65%7.23%11.16%2.11%6.73%
Dividend Yield
1.80%1.52%----
Payout Ratio
17.63%14.86%23.82%23.05%--
Buyback Yield / Dilution
2.90%2.01%-2.49%-0.07%0.05%-0.04%
Total Shareholder Return
4.70%3.53%-2.49%-0.07%0.05%-0.04%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.